Afuco™ Anti-Human CGRP ADCC Therapeutic Antibody (ALD403), ADCC Enhanced
Anti-CGRP ADCC Enhanced Antibody (ALD403) is an ADCC enhanced antibody produced by our Afuco™ platform. ALD403 is a novel monoclonal antibody targeted to calcitonin gene-related peptide, or CGRP, for migraine prevention. CGRP is a validated target that is believed to play a key role in migraine.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-153CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | CGRP |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Short term: store at 4°C (over 6 months), long term: -20°C or -80°C. |